(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that current evidence is insufficient for assessing the balance of harms and benefits of screening for elevated blood lead levels in asymptomatic children and pregnant women. These findings form the basis of a draft recommendation statement published online Oct. 30.

Source link